HPV mRNA E6/E7; ThinPrep® Imaging System Pap
Liquid based Pap testing is intended for use in the screening and detection of cervical cancer, pre-cancerous lesions, atypical cells and all other cytologic categories as defined by the Bethesda System for reporting results of cervical cytology. Pap screening is not reliable for the detection of endometrial cancer.
Liquid Cytology (PreservCyt®) Preservative (ThinPrep®) collected in a ThinPrep® vial
42 days Ambient (transport)
Refrigerated and frozen=unacceptable
Aliquot PreservCyt® solution before or after performance of liquid based cytology testing.
PreservCyt®: Transfer 1 mL of PreservCyt® solution into Aptima® vaginal collection tube (orange label) or Aptima® specimen transfer tube (green label).
Please refer to Interpretive Report
Liquid based Pap testing is intended for use in the screening and detection of cervical cancer, pre-cancerous lesions, atypical cells and all other cytologic categories as defined by the Bethesda System for reporting results of cervical cytology. Pap screening is not reliable for the detection of endometrial cancer.
5 to 7 days
88175 (HCPCS: G1045), 87624